Drug Profile
Zopolrestat
Alternative Names: Alond; CP 73850; XediaLatest Information Update: 14 Jul 2000
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic cardiomyopathy; Diabetic nephropathies; Diabetic neuropathies
Most Recent Events
- 14 Jul 2000 Discontinued-II for Diabetic cardiomyopathy in USA (PO)
- 14 Jul 2000 Discontinued-II for Diabetic nephropathies in USA (PO)
- 23 Jun 2000 Pfizer has merged with Warner-Lambert